Cannabis News
How Likely is Cannabis Rescheduling, Now?
Published
8 months agoon
By
admin
The potential rescheduling of cannabis to Schedule III has been met with a mix of celebration and skepticism within the industry. While many view this as a significant step forward, I find myself in the camp of cautious observers. As someone who has closely followed and written about cannabis policy, I’ve long maintained that Schedule III is less about progress and more about creating a sweet spot for Big Pharma to dominate the cannabis market, leaving smaller players and consumers at a disadvantage.
However, the path to rescheduling is far from clear-cut. Depending on who you ask, you’ll hear vastly different predictions about the likelihood and timeline of this potential shift. The waters are murky, with legal experts, industry insiders, and politicians all weighing in with their own perspectives and agendas.
In this article, we’ll dive deep into the opinions of various stakeholders. We’ll examine the insights shared by legal experts at a recent conference in Chicago, who emphasized the uncertainty surrounding the rescheduling process. Their cautious approach stands in contrast to the more optimistic outlook of a prominent cannabis businessman with significant skin in the game.
By presenting these diverse viewpoints, my aim is not to push a particular narrative, but to provide you with a comprehensive overview of the current landscape. I invite you to consider the evidence, weigh the arguments, and form your own conclusions about the likelihood and potential impacts of cannabis rescheduling.
As we navigate through these expert opinions, keep in mind that the cannabis industry is no stranger to unexpected turns and political maneuvering. What seems certain today may shift dramatically tomorrow. So, let’s embark on this exploration of the complex and often contradictory world of cannabis policy reform, and see what insights we can glean about the potential future of marijuana’s legal status in the United States.
The International Cannabis Bar Association recently convened in Chicago, bringing together a cadre of legal experts to discuss the intricacies of cannabis law and policy. Among the hot topics at this gathering was the potential rescheduling of cannabis to Schedule III, a move that could dramatically reshape the industry landscape.
Kelly Fair, a San Francisco-based cannabis attorney, set the tone for the discussions, emphasizing the prevailing uncertainty: “We don’t know what’s going to happen. The only thing we’re certain about today is that we’re uncertain about what’s going to happen.” This sentiment echoed throughout the conference, with experts grappling with the complexities of the rescheduling process and its potential outcomes.
While some experts entertained the possibility of swift action, most remained cautious about the timeline. Fair suggested that in a best-case scenario, “there’s a final rule that gets announced in August.” However, this optimistic view was tempered by Robert Tobiassen, president of the National Association of Beverage Importers, who called such a six-month timeframe “unbelievably ambitious.”
The legal experts identified several potential hurdles that could impede the path to Schedule III:
-
Political Uncertainty: The looming presidential election adds a layer of complexity. As Michael Joseph Heaton, a cannabis attorney and lobbyist, pointed out, “A Harris-whoever administration… would probably be, I think, more aggressive than the current Biden administration” in supporting federal cannabis reform. Conversely, “a Trump-Vance administration, where we probably will see most of this go away.”
-
Administrative Processes: The DEA has nearly 43,000 public comments to digest before proceeding, which could significantly slow the process.
-
Potential Legal Challenges: Cannabis opponents, such as Smart Approaches to Marijuana (SAM), have promised to attempt to block rescheduling through legal action.
-
Congressional Interference: Heaton highlighted attempts by Republican opponents to use backdoor methods through Congressional appropriations to halt rescheduling, including introducing amendments to withhold funding for the move.
-
International Treaty Obligations: The experts noted that U.S. obligations under international treaties could impact the final rule.
Despite these challenges, there seemed to be a cautious consensus among the legal experts that rescheduling to Schedule III is more likely than not to occur. However, the timeline remains a point of contention. While some optimistically pointed to the possibility of a final rule by August, most experts viewed this as highly ambitious.
Tobiassen refused to speculate on specific timing, emphasizing the multitude of unknowns in play. He suggested that the outcome of the November election could significantly impact the process, potentially leading to either accelerated reform or a complete reversal of progress.
Overall, the legal experts at the Chicago conference painted a picture of a complex, uncertain process with high stakes for the cannabis industry. While they generally believed that rescheduling to Schedule III is on the horizon, they stressed that the path forward is far from straightforward. They urged industry stakeholders to remain vigilant and engaged in the political process, as the coming months and years could bring significant changes to the federal status of cannabis.
While legal experts express caution, Jason Vedadi, CEO of Story Cannabis, offers a more bullish perspective on cannabis rescheduling. Vedadi is no newcomer to the industry; he’s a real estate developer and cannabis industry pioneer who served as executive chairman of Harvest Health and Recreation. He took Harvest Health public in 2018 and was its largest shareholder until the company was acquired in a $2.1-billion deal with Trulieve in 2021.
Vedadi’s optimism about rescheduling is palpable. “I understand why people are completely skeptical and that they think the rug’s going to get pulled out from underneath them,” he acknowledges. “I also can relate to that kind of mentality in this industry, but if you ask me where my true gut instinct is on this, this is kind of a done deal.”
His confidence stems from the process itself. Vedadi points out that the rescheduling initiative has been ongoing since 2022 and has progressed exactly as expected. This consistency in the process fuels his belief that rescheduling is more than just a possibility—it’s a near certainty.
However, Vedadi isn’t blind to the potential risks. He acknowledges that if rescheduling isn’t completed before the end of Biden’s term, particularly if Democrats lose the White House, there’s an element of uncertainty. “If Democrats are reelected, then I would say there’s zero risk to Schedule III. If Republicans are elected, it adds an element of risk and, I think, some discomfort for people,” Vedadi explains.
The ideal scenario, according to Vedadi, would be for rescheduling to occur before the November elections. This would eliminate the risk of a potential Republican administration halting or reversing the process. However, he also notes that even during the Trump administration, there wasn’t active opposition to state-level cannabis reforms: “If you go back to Trump, he didn’t do anything for four years. He didn’t stop anything. He didn’t prosecute anybody. He didn’t push any agenda.”
Despite his optimism, Vedadi recognizes that completing the rescheduling process before November is unlikely. The DEA still has to review over 43,000 public comments, and there’s potential for administrative law hearings or legal challenges that could extend the timeline.
This delay in the process lends credence to the theory that the push for Schedule III rescheduling is, at least in part, a political maneuver. By keeping the issue alive through the election cycle, Democrats can position themselves as progressive on cannabis reform, potentially swaying voters who prioritize this issue.
Vedadi doesn’t directly address this political angle, focusing instead on the business implications of rescheduling. He emphasizes that for EBITDA-positive companies, rescheduling “changes everything,” potentially providing more cash flow, growth capital, and improved relationships with lenders.
While Vedadi’s optimism provides a counterpoint to the cautiousness of legal experts, it’s clear that the path to Schedule III is not without its hurdles. Whether his confidence is well-founded or overly optimistic remains to be seen as the rescheduling process continues to unfold in the coming months.
Despite the optimism of industry insiders and the cautious analysis of legal experts, the truth remains that nobody can predict with certainty how the cannabis rescheduling saga will unfold. My gut feeling, however, is that Schedule III may be a pipe dream—or if achieved, it could be short-lived.
A significant hurdle emerged with the recent rescinding of the Chevron Doctrine by the Supreme Court. This doctrine, which previously gave federal agencies like the DEA broad authority to interpret ambiguous statutes, has been overturned. Its absence opens the door for anti-cannabis groups to wage legal battles against rescheduling, potentially tying up the process in courts for years.
Moreover, with the November elections looming and Trump’s popularity seemingly unscathed—or even boosted—by recent legal challenges, the political landscape remains unpredictable. This uncertainty makes it increasingly likely that cannabis will remain in a state of limbo, caught between progressive promises and conservative resistance.
But here’s the crux of the matter: Schedule III is not what the cannabis community truly desires. It’s a half-measure, a “bread and circuses” approach that fails to address the core issues. What we really want—and need—is full deregulation. We want the freedom to grow our own plants, to have access to this plant without government interference or corporate monopolization.
The push for Schedule III feels like a political ploy, a way for politicians to appear progressive on cannabis without truly committing to comprehensive reform. It’s a compromise that ultimately serves neither the industry nor the consumers effectively.
So, regardless of whether cannabis ends up in Schedule III or remains in its current classification, our focus should remain unwavering. We must continue to push for full decriminalization and legalization. We should advocate for policies that allow home cultivation and remove government oversight from personal cannabis use.
The sticky bottom line is this: don’t be distracted by the promise of incremental change. Keep your eyes on the prize—complete cannabis freedom. Anything less is just smoke and mirrors in the grand scheme of drug policy reform.
RESCHEDULING CANNABIS WINNERS AND LOSERS, READ ON…
WHO ARE WINNERS, WHINERS, AND LOSERS FROM CANNABIS RESCHEDULING?
You may like
-
Experience CannaLand, the one-of-a-kind celebration presented by Deep Stories
-
Couple arrested with large amounts of weed and molly
-
The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!
-
Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place
-
Oklahoma voters could weigh in on adult-use marijuana legalization in 2026
-
Karma Koala Podcast 247: Speaking with Dr. Natalie Corthésy senior lecturer university of West Indies & Enrico Bonadio professor of law City St George’s University of London about their forthcoming Edward Elgar title, “Intellectual Property and Cannabis”
Cannabis News
The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!
Published
2 days agoon
April 5, 2025By
admin
The Rescheduling Ruse: Why I Told You So
In a move that surprised absolutely no one who’s been paying attention, the White House recently announced it has “no action planned” on marijuana reform. Yes, the same marijuana reform that President Trump enthusiastically backed on the campaign trail just weeks before Election Day.
The writing was on the wall all along, folks. I’ve been telling you for months that the much-hyped rescheduling of cannabis from Schedule I to Schedule III was nothing more than political theater – a carefully choreographed dance designed to generate headlines without delivering substantive change. And here we are, with yet another administration putting cannabis reform on the back burner while millions of Americans continue to live under the shadow of failed prohibition policies.
Don’t get me wrong – I’m not here to play political favorites. This isn’t a red versus blue issue. The Biden administration dangled the same carrot, initiating a rescheduling process that conveniently stalled due to “complications” with DEA hearings. Different players, same game.
Let’s take a step back and examine what’s really happening here, because the truth about cannabis reform in America is both simpler and more complex than most people realize.
Trump’s pre-election cannabis conversion was quite the spectacle, wasn’t it? Suddenly, the man who selected Jeff “Good People Don’t Smoke Marijuana” Sessions as his first Attorney General was voicing support for rescheduling, banking access, and even Florida’s legalization initiative.
But as CNN recently reported, “no action is being considered at this time.” The honeymoon didn’t even last through the first dance. The administration’s priorities lie elsewhere – immigration, government spending, foreign policy – while cannabis reform gets shelved alongside countless other campaign promises.
Interestingly, CNN did note that Trump and his transition team attempted to include cannabis banking protections in December’s government funding resolution. This behind-the-scenes effort suggests at least some genuine interest in the issue, but hardly qualifies as the bold reform millions of voters were led to expect.
This pattern should feel familiar. The Biden administration made similar overtures, with the president announcing pardons for federal marijuana possession offenses and directing an administrative review of cannabis scheduling. That process dragged on for over a year, with the DEA repeatedly delaying final action. Biden got the headlines; cannabis users got nothing.
The harsh reality? Cannabis reform makes for good campaign fodder, but terrible governance priorities. Once elected, the political calculus changes dramatically. The motivation to deliver evaporates when the votes are already counted and the special interests start calling in their favors.
At the heart of this perpetual delay lies the Drug Enforcement Administration – an agency whose very existence depends on the continuation of the drug war. Expecting the DEA to facilitate cannabis reform is like asking a turkey to vote for Thanksgiving.
The DEA has mastered the art of procedural obstruction. Under Biden, they scheduled hearings, requested extensions, and effectively ran out the clock. Under Trump, they appear poised to do absolutely nothing, perhaps not even bothering with the pretense of consideration.
The pattern becomes clearer when you look at Trump’s cabinet picks. His nominee to lead the DEA, Terrance Cole, has previously voiced serious concerns about marijuana dangers and linked its use to higher suicide risk among youth. His HHS general counsel nominee, Mike Stuart, is so staunchly anti-cannabis that prohibitionist groups openly celebrated his selection.
Even Robert F. Kennedy Jr., who previously supported legalization, has walked back his stance since being confirmed as HHS Secretary, stating he’s “worried about” high-potency marijuana and deferring to the DEA on rescheduling.
When you stack the regulatory deck with cannabis skeptics, you’ve telegraphed your true intentions no matter what you said on the campaign trail.
Here’s what I’ve been saying all along: meaningful cannabis reform was never going to come from the White House, regardless of who occupied it. The DEA will never willingly relinquish its power, and politicians will always prioritize easier wins over controversial reforms.
The only real path forward is through Congress completely removing cannabis from the Controlled Substances Act. Full stop. No rescheduling, no administrative reviews, no half-measures. Cannabis needs to be descheduled entirely, returning regulatory authority to the states where it belongs.
But while we push for that goal, the real revolution continues on two fronts.
First, state-by-state legalization marches forward. Despite federal inaction, 38 states have medical marijuana programs, and 24 states plus DC have legalized adult use. Each new state that joins the ranks weakens prohibition’s grip and demonstrates the failure of federal policy.
Second, and perhaps more powerful, is what I call “mass defiance of an unjust law.” Every day, millions of Americans peacefully consume cannabis in direct violation of federal law. They grow it in their homes, share it with friends, and build communities around it. This civil disobedience at scale is perhaps the most effective weapon against prohibition.
The federal government simply doesn’t have the resources to enforce cannabis prohibition against a population that increasingly rejects it. When enough people break an unjust law, the law itself becomes unenforceable.
I hate to say I told you so, but… I told you so. The rescheduling promise was never going to materialize, regardless of who won the White House. It was a political mirage, designed to attract voters while requiring minimal commitment.
But don’t mistake my cynicism about federal action for pessimism about our cause. Cannabis reform is happening – it’s just happening from the ground up rather than the top down. Every state that legalizes, every municipality that decriminalizes, every voter who demands change, and yes, every person who peacefully consumes despite prohibition is part of this unstoppable movement.
The lesson here is simple: Don’t put your faith in presidential promises or administrative processes. Put it in your local ballot initiatives, your state legislators, and your own power to reject unjust laws through peaceful non-compliance.
Cannabis prohibition is dying, not because presidents commanded it, but because we the people have decided it must end. That’s the real power in our democracy – not the fleeting promises of politicians, but the sustained will of the citizens.
So next time a candidate promises to fix cannabis laws, remember this moment. Then go out and fix them yourself, one vote, one state, and one act of principled defiance at a time. That’s how real change happens in America, and that’s how we’ll finally end cannabis prohibition once and for all.
CANNABIS UNDER TRUMP 2.0, READ ON…
Cannabis News
Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place
Published
2 days agoon
April 5, 2025By
admin
Quitting Won’t Fill the Hole
There’s a pervasive notion that floats around recovery circles—this idea that once you kick your habit, everything will magically fall into place. The clouds will part, the birds will sing, and suddenly life will be worth living again. While it’s true that being addicted to a “thing,” whether substance or act, eventually tallies up consequences that weigh heavy on our souls, the math isn’t quite as simple as “remove addiction, add happiness.”
I’ve watched countless cannabis enthusiasts (and addicts of all stripes) fall into this trap. They sit in circles, eyes gleaming with hope as they declare, “If I could only quit, then everything would be better…” But they’re missing something crucial—their addiction isn’t the source of their discontent; it’s merely a symptom of something deeper.
Addiction, at its core, is a means of dealing with something we cannot name or are desperately trying to avoid. It’s the bandage we slap over a wound without cleaning it first. The cannabis, the alcohol, the gambling, the endless scrolling—these aren’t the disease itself but rather the body’s misguided attempt at self-medication.
Here’s the uncomfortable truth that most recovery programs don’t emphasize enough: if you don’t do the real healing, even if you manage to white-knuckle your way through quitting one addiction, you’ll inevitably find something else to cover that gaping wound. Maybe you’ll trade joints for junk food, or bongs for binge-watching. The face of the addiction changes, but the role it plays remains constant.
Let’s take a deeper dive into this cycle and why simply quitting isn’t enough to truly heal.
First, we must acknowledge that when it comes to pain and addiction, everyone’s journey is unique. What feels like an insurmountable mountain to you might be a speed bump to someone else, and vice versa. There’s no universal scale for suffering, which makes navigating these waters all the more complex.
However, across all these varied experiences, there’s a common trap I’ve seen ensnare countless individuals—what I call the “If/Then Fallacy.” It’s the belief that one singular thing is the root cause of all our discomfort. This is where addicts often say, “If I can only kick this addiction, then my whole life would be better.” While this may seem logical on paper, it’s a deeply flawed perspective.
The real issue rarely lies with the substance or behavior itself but with something deeper—something the addiction is helping us avoid or cope with. Whether it’s trauma, depression, anxiety, or simply the existential weight of being human in an increasingly disconnected world, there’s usually a wound beneath the bandage.
Furthermore, the “If/Then” scenario places your healing, joy, and accomplishments in a fictional future state. “If I stop smoking weed, then I’ll finally have the motivation to start that business.” “If I quit drinking, then my relationship will improve.” These statements create a dangerous binary—because when the “if” is satisfied but the “then” doesn’t materialize, where does that leave you? Often, it leads to “If that didn’t work, then what’s the point of trying anything?”
This thinking creates a perfect setup for relapse or substituting one addiction for another. After all, if quitting didn’t magically transform your life as promised, why continue to deny yourself that temporary relief?
If you’ve been considering quitting cannabis or any other addiction, and you believe it to be the sole source of your unhappiness, I strongly urge you to reconsider your framework. The cannabis, or your relationship with it, is likely just a mask for your real pain. If you want to truly liberate yourself from the burden of addiction, you need to develop the capacity to sit with your pain, examine it, and cultivate joy despite it—not because it disappeared.
This article was inspired by a post I came across while scrolling through Reddit the other day—one of those moments where someone’s raw honesty stops you mid-scroll. A 32-year-old man shared that after smoking cannabis and drinking 4-6 beers daily for nearly his entire 20s, he had finally managed to quit both. No cannabis for almost six months, no alcohol for three. A significant achievement by any measure.
Yet instead of the transformation he expected, he felt “MISERABLE.” Despite taking medication for ADHD and anxiety, and despite removing substances that conventional wisdom says should improve his mental health, he felt no positive change. In fact, he felt worse, as if he’d “stopped doing things that were fun for me, or at least making life bearable.”
His post ended with a plea that broke my heart: “Is this just how I’m going to feel now? Does this go away eventually?”
This redditor’s experience perfectly illustrates the point—even when you manage to power through the physical and psychological challenges of quitting an addiction, your mental and spiritual state doesn’t necessarily transform as a result. His baseline remained exactly the same, perhaps even dipping lower without the chemical crutches he’d relied on for so long.
When you’re changing habits but not experiencing the promised benefits, it’s a clear sign that your discomfort or pain isn’t primarily coming from the substance. The cannabis or alcohol wasn’t creating your misery—it was masking it, providing temporary relief from a deeper issue that remains unaddressed.
This is something we all must consider when facing our compulsions. If you find yourself in a situation where you want to stop a behavior but simply can’t, it might be time to look deeper. Ask yourself, “Why do I do this activity?” And then ask “why” five more times, each answer digging a layer deeper toward the root cause.
Why do I smoke cannabis every night? Because it helps me relax. Why do I need help relaxing? Because my mind races with anxiety. Why does my mind race with anxiety? Because I’m worried about my future. Why am I worried about my future? Because I don’t feel secure in my career path. Why don’t I feel secure in my career path? Because I never really chose it—I fell into it. Why does that bother me? Because I feel like I’m not living authentically or pursuing my true passions.
Once you’ve excavated to this deeper level, you can begin to address the root causes directly. Perhaps the issue isn’t the cannabis at all, but rather that you need to reassess your career path or find meaning outside of work. Without this deeper work, quitting the substance becomes an exercise in willpower rather than healing.
Your addiction isn’t necessarily the root cause of your issues—it’s often just the most visible symptom. If you’re depressed, anxious, or feeling lost, it’s not primarily because of the substance; it’s because of something deeper that the substance helps you manage or forget temporarily.
Unless you actually do the internal work on these matters—examining your pain, seeking appropriate mental health support, rebuilding healthy relationships, finding meaning and purpose—no matter what you quit or how long you stay “clean,” you’ll likely find yourself seeking new ways to shield yourself from the pain. The prison isn’t cannabis or alcohol; it’s the unhealed wound those substances help you endure.
If you’re struggling right now, it’s absolutely important to seek help. That might mean therapy, support groups, or speaking with a healthcare provider about potential underlying mental health conditions that need treatment. But alongside that external support, commit to the honest and difficult work of looking inward. Ask yourself what you’re truly trying to avoid when you reach for that joint or that drink.
At the end of the day, we all have our struggles. If yours involves cannabis at this point in your life, there’s no judgment here. I’ve been there myself. But I’ve also learned that true healing rarely comes from simply removing something from your life—it comes from adding understanding, self-compassion, and addressing the real gaps in your heart and mind that the substance was never capable of filling in the first place.
The void can’t be filled by quitting. But quitting might just give you the clarity to finally see what the void truly needs.
QUITTING CANNABIS, READ ON…
THE STONER’S GUIDE TO QUITTING WEED – WAIT, WHAT…WHY?
Cannabis News
Scientists Now Think That One Compound in the Cannabis Plant Can Replace All Opiates
Published
4 days agoon
April 3, 2025By
admin
Which Cannabis Compound Do Scientists Think Can Replace Opiates?
…And Why This Is Important
Opiates are a type of pharmaceutical drug that’s been made from the opium poppy plant. While it’s somewhat a ‘natural’ substance that’s been extracted from the fibers and sap of the opium poppy plant, these are extremely dangerous sedatives that act on the central nervous system. However, there are completely synthetic opioids as well, which are manufactured entirely in laboratories.
Famous examples of well-known and widely-used opiates today include heroin, codeine, and morphine. They all work similarly, binding to the brain’s opioid receptors and users feel a drastic reduction in pain. It also causes users to feel euphoric, drowsy, or sleepy. Common side effects include constipation and nausea.
Because opiates are powerful for dulling one’s pain perceptions, they have become commonly prescribed by doctors and hospitals for pain relief. That said, opiates have become one of the world’s most addictive, dangerous, and fatal drugs – and you can get prescribed it right by your very own physician. Repeated use of opiates can easily lead to dependence and addiction, and eventually consuming high doses can drastically slow down breathing, and cause brain damage, or even death.
Since doctors still keep prescribing opioids, this has resulted in the deadly Opioid Epidemic, which has killed thousands of people. It’s a worrisome public health crisis, most especially because of fentanyl, an illegally manufactured opioid which is said to be 50 times more potent than heroin.
Could The Answer To The Opioid Epidemic Lie In Cannabis…Terpenes?
The past few years have shown that cannabis legalization is critical for surviving the opioid epidemic, and reducing overall opioid consumption.
The results of a recent research paper, which builds on past studies conducted by Dr. John Streicher, who is a member of the Comprehensive Center for Pain and Addiction, reveals fascinating findings. According to Streicher, cannabis terpenes were found to provide relief in inflammation models as well as on neuropathic pain caused by chemotherapy.
For the study, Streicher and his research team analyzed 4 kinds of terpenes that are found in mid to high levels in Cannabis sativa plants: linalool, geraniol, beta-caryophyllene, and alpha-humulene. They discovered that each terpene produced significant pain relief among mice subjects with fibromyalgia and post-operative pain, and among the terpenes, geraniol was found to be the most powerful.
“Our research is showing that terpenes are not a good option for reducing acute pain resulting from an injury, such as stubbing your toe or touching a hot stove; however, we are seeing significant reductions in pain when terpenes are used for chronic or pathological pain,” he said. “This study was the first to investigate the impact of terpenes in preclinical models of fibromyalgia and post-operative pain and expand the scope of potential pain-relieving treatments using terpenes,” Streicher said.
Cannabis terpenes are the compounds responsible for the aromatic profile of each strain; they are located in the plant trichomes. Not only do they contribute to each strain’s unique flavor and odor, but they also have valuable therapeutic and medicinal benefits. There are around 150 kinds of terpenes known today, though in the entire plant world, there are known to be some 20,000 terpenes.
Understanding the therapeutic benefits of terpenes is incredibly valuable also because they don’t contain THC (tetrahydrocannabinol), the compound in marijuana that gets you high.
“With fibromyalgia, there isn’t much of an understanding of what the pain state is, and there are not a lot of great options for treating it,” explains Streicher. “Our findings show that terpenes may be a viable treatment option for fibromyalgia pain, which could potentially have a large impact and make a difference for an under-treated population.”
Other Studies
This is not the first time that cannabis terpenes have been found to demonstrate excellent pain-relieving properties. It must be noted that just like what Streicher says, terpenes seem to do better with chronic pain management, instead of acute pain management.
Another study from 2024, which was published in The Journal of the Association for the Study of Pain, was conducted by researchers at the University of Arizona and the National Institutes of Health. The investigators analyzed the analgesic properties of different terpenes including geraniol, humulene, linalool, pinene, and caryophyllene among mice subjects with chemotherapy-induced peripheral neuropathy.
According to the researchers, all the terpenes delivered analgesic effects that were equivalent to around 10 mg/kg of morphine. It was also interesting to note that administering both morphine and terpenes together at low doses resulted in ‘enhanced’ pain-killing effects.
“Together these studies identify cannabis terpenes as potential therapeutics for chronic neuropathic pain,” said the investigators.
There have also been other studies that have found that combining cannabis with opioids can indeed provide long-lasting pain relief. It comes with the added benefit of reducing opioid doses needed for effective pain control. This phenomenon is called opioid-sparing. These types of protocols can be beneficial for patients who suffer from severe, chronic pain caused by cancer, arthritis, joint problems, fibromyalgia, diabetes, post-surgical pain, migraines, nerve damage, and so much more.
Conclusion
Learning more about the pain-killing properties of terpenes is extremely valuable for the medical community, patients, and even society as a whole. We can all do with less opioid addictions because it has torn families apart, and caused the deaths of thousands of people.
Terpenes, or cannabis in general, offer a natural and safe alternative that can be complementary to other pharmaceutical treatments designed to reduce pain.
SWAPPNG OPIOIDS FOR CANNABIS, READ ON…

Experience CannaLand, the one-of-a-kind celebration presented by Deep Stories

Couple arrested with large amounts of weed and molly

The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!

Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place

Oklahoma voters could weigh in on adult-use marijuana legalization in 2026

Karma Koala Podcast 247: Speaking with Dr. Natalie Corthésy senior lecturer university of West Indies & Enrico Bonadio professor of law City St George’s University of London about their forthcoming Edward Elgar title, “Intellectual Property and Cannabis”

MJBizCon offers speakers chance to share cannabis insights, shape industry

The Best Tariff Friendly Cocktails

Cannabis Consumers Are Being Hit By The Tariffs

The Best Tips To Update Your Wardrobe

Distressed Cannabis Business Takeaways – Canna Law Blog™

United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)

What you Need to Know

Drug Testing for Marijuana – The Joint Blog

NCIA Write About Their Equity Scholarship Program

It has been a wild news week – here’s how CBD and weed can help you relax

Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022

A new April 20 cannabis contest includes a $40,000 purse

Your Go-To Source for Cannabis Logos and Designs

UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing1 year ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse